Cellares
Cellares is seeking a Systems Engineer (or similar engineering role) to support its Integrated Development and Manufacturing Organization focused on cell therapy manufacturing. The position is based onsite in South San Francisco, CA, and offers a salary range of $124,051 to $137,668 per year. Candidates should have a master's degree in Engineering, Physics, or Biotech Automation and at least one year of relevant experience, including proficiency with MATLAB or Python and a data visualization or statistical tool.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
2019
Cellares is the first Integrated Development and Manufacturing Organization (IDMO) that applies an Industry 4.0 approach to mass manufacture the “living drugs” of the 21st century. The company develops and operates integrated technologies and automated manufacturing systems for cell therapies to accelerate access to life‑saving treatments. By combining development, engineering, and scalable production, Cellares aims to simplify and industrialize cell therapy manufacturing. It positions itself as a platform-driven partner for bringing next‑generation cell therapies to patients more reliably and at scale.
Cellares Secures $257 Million Series D to Revolutionize Cell Therapy Manufacturing
1 month ago
Cellares Raises $257 Million Series D Led by BlackRock and Eclipse to Industrialize Global Cell Therapy Manufacturing with Breakthrough Automation
1 month ago
Cellares raises $257M Series D to automate cell therapy manufacturing
1 month ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Cellares.
82% above the average for this role
Cellares' series D round draws $257M as cell therapy contractor takes operations global
1 month ago